Could breast cancer survivors face higher colon cancer risk?
NCT ID NCT07678099
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study investigates whether women who have completed breast cancer treatment have a higher chance of developing colorectal polyps or colon cancer. Researchers will perform screening colonoscopies in 216 asymptomatic breast cancer survivors and check for abnormal growths. The goal is to understand if shared risk factors mean these women need earlier or more frequent colon cancer screening.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Screening colonoscopy
- What this could lead to
- If breast cancer survivors are found to have more colorectal polyps, this could lead to personalized screening guidelines to catch colon cancer earlier in this group.
- What could go wrong
- This is an observational study, not a treatment trial. It may not find a strong link, and results may not apply to all breast cancer survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
216 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Nov 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged ≥18 years * Diagnosis of breast cancer * Completed surgical and/or systemic treatment * Underwent or planned to undergo screening colonoscopy after completion of breast cancer treatment * Asymptomatic at the time of colonoscopy Exclusion Criteria: * Age \<18 years * History of colorectal malignancy * History of inflammatory bowel disease * Inadequate bowel preparation (Boston Bowel Preparation Scale not adequate) * Incomplete medical records * Refusal to participate * Colonoscopy performed for diagnostic purposes rather than screening * Presence of gastrointestinal alarm symptoms (e.g., rectal bleeding, iron deficiency anemia, change in bowel habits, weight loss, abdominal pain, positive FIT/FOBT, or suspicious radiologic findings)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Haydarpasa Numune Research and Training Hospital
Istanbul, Uskudar, 34668, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a lab test tell which chemo works for colon cancer?